6th Aug 2008 16:04
|
Press Release |
6 August 2008 |
Cyprotex PLC
("Cyprotex" or "the Company")
Cyprotex PLC (AIM:CRX), the drug discovery, technology and information company, today announces that it has issued 50,000 new ordinary shares of 0.1p each ("new Ordinary Shares") pursuant to the exercise of options.
The issue of these new Ordinary shares is subject to the new Ordinary Shares being admitted to trading on AIM, application for which has been made. Trading in the new Ordinary Shares, which will rank pari passu in all respects with the existing ordinary shares, is expected to commence on 8 August 2008.
Ends -
For further information:
Cyprotex PLC
Anthony Baxter Tel: +44 (0) 1625 505100
Chief Executive Officer
Russell Gibbs
Chief Financial Officer
www.cyprotex.com
Nomura Code Securities Limited
Charles Walker Tel: +44 (0) 20 7776 1200
Giles Balleny
Related Shares:
CRX.L